In the third dispatch of our special series 'Future of Dealmaking Season 2: Capital Privado', Ankur Thadani, Partner, TPG Growth and Rise; Rupinder Malik, Partner, JSA, and Sidharth Shankar, Partner, JSA come together to discuss the investment trajectory of the life sciences sector in a post-Covid world. According to Thadani, the impact of the pandemic on he ... Show More
May 2021
Future of Dealmaking: Decoding private equity in the age of coronavirus | Part 2
As companies around the world reel from the unprecedented disruption of the coronavirus pandemic, private equity may emerge as a source of capital uniquely suited to help businesses weather the storm, while, in turn, putting money to work in transactions at favorable valuations. ... Show More
43m 10s
Sep 24
Who Loses—and Maybe Wins—From Trump’s New H-1B Fee
On this episode of Trumponomics, host Stephanie Flanders explores US President Donald Trump’s decision to impose a $100,000 fee on new H-1B visa applications, which industries will lose the most from this new expense for foreign workers and a potential long-term silver lining for ... Show More
24m 4s
Aug 5
US’ Tariff Blow: What can India Do?
What happens when economic friction between two global partners sparks deeper strategic questions? In this episode of The Morning Brief, host Anirban Chowdhury talks to Agneshwar Sen, trade policy leader, EY India, to unpack the implications of recent US tariff on India and threa ... Show More
26m 23s
Mar 2025
Trump’s Tariff Salvo at India: The Geopolitics
What does a trade deal with the US really mean for India? How can we strengthen our global trade position while keeping crucial partnerships in defense, technology, and space safe from political crossfire? In this candid conversation, host Anirban Chowdhury sits down with ET’s Pr ... Show More
13m 7s